MEDERMA STRETCH MARKS THERAPY- dimethicone cream 
HRA Pharma America, Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

DRUG FACTS

ACTIVE INGREDIENTSPURPOSE
Dimethicone 2%Skin Protectant

USES • Temporarily protects and helps relieve chapped or cracked skin

WARNINGS • For external use only

When using this product • Do not get into eyes

Stop use and ask a doctor if • Condition worsens • Symptoms last more than 7 days or clear up and occur again within a few days

Do not use on • Deep or punctured wounds • Animal bites • Serious burns

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

DIRECTIONS • Apply as needed

OTHER INFORMATION • Store at room temperature

INACTIVE INGREDIENTS • Water, Cetearyl Alcohol, C12-15 Alkyl Benzoate, Pentylene Glycol, Dicaprylyl Carbonate, Glycerin, Arachidyl Alcohol, Alcohol, Cyclopentasiloxane, Behenyl Alcohol, Cyclohexasiloxane, Ethoxydiglycol, Arachidyl Glucoside, Allium Cepa (Onion) Bulb Extract, Cetearyl Glucoside, Tocopheryl Acetate, Sodium Hyaluronate, Fragrance, Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Hydroxyethylcellulose, Disodium EDTA, Hydrolyzed Collagen, Asiaticoside, Asiatic Acid, Madecassic Acid, Polysorbate 60, Sorbitan Isostearate, Hydrolyzed Soy Protein, Sodium Hydroxide, Tocopherol, Iron Oxides, Sodium Benzoate

QUESTIONS OR COMMENTS? • For more information call 1-833-426-6733 or visit www.mederma.com

PRINCIPAL DISPLAY PANEL

MEDERMA®

Stretch Marks
Therapy

Clinically shown to treat
stretch marks by:

  • Hydrating the skin
  • Reducing discoloration
  • Improving texture

No 1 
Doctor & Pharmacist
recommended stretch marks brand*

Skin Protectant
1x CREAM TUBE
NET WT. 5.29 Oz (150g)

Unique Triple-Action
Formula penetrates
into the skin

Mederma® Stretch Marks
Therapy is an intensive
cream bringing together
a unique blend of
ingredients including:

  • Cepalin®
  • Hyaluronic Acid
  • Centella Asiatica Extract

to visibly reduce stretch marks
and hydrate skin.

Unique Triple-Action
Formula
penetrates
beneath the surface
of the skin to help:

  • Collagen production
  • Cell renewal
  • Lock-in moisture

Used daily:
Mederma® Stretch Marks
Therapy's nourishing formula
hydrates skin to help prevent
stretch marks and is clinically
shown to improve the appearance
of existing stretch marks.

For best results:
Apply 2 times a day in the morning
and evening. Gently and evenly
massage Mederma® Stretch Marks
Therapy in a circular motion on all
areas of the body you wish to treat.

After 4 weeks

  • See visible results

After 12 weeks

  • See greater improvements

Mederma® Stretch Marks Therapy
is safe to use while breastfeeding
and during pregnancy from
the second trimester.

*No. 1 recommended brand
of scar reduction treatments

Manufactured for Laboratoire HRA Pharma
Distributed by: HRA Pharma America, Inc.
Morristown, NJ 07960.
Made in Germany.
Mederma® is a registered trademark of HRA Pharma.

Guaranteed
results or your
money back

LOT No

EXP DATE

UPC 810000318100

Carton Label
MEDERMA STRETCH MARKS THERAPY 
dimethicone cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:73302-204
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
dimethicone (UNII: 92RU3N3Y1O) (dimethicone - UNII:92RU3N3Y1O) dimethicone2 g  in 100 g
Inactive Ingredients
Ingredient NameStrength
water (UNII: 059QF0KO0R)  
Cetostearyl Alcohol (UNII: 2DMT128M1S)  
Alkyl (C12-15) Benzoate (UNII: A9EJ3J61HQ)  
Pentylene Glycol (UNII: 50C1307PZG)  
Dicaprylyl Carbonate (UNII: 609A3V1SUA)  
Glycerin (UNII: PDC6A3C0OX)  
Arachidyl Alcohol (UNII: 1QR1QRA9BU)  
Alcohol (UNII: 3K9958V90M)  
Cyclomethicone 5 (UNII: 0THT5PCI0R)  
Docosanol (UNII: 9G1OE216XY)  
Cyclomethicone 6 (UNII: XHK3U310BA)  
Diethylene Glycol Monoethyl Ether (UNII: A1A1I8X02B)  
Arachidyl Glucoside (UNII: 6JVW35JOOJ)  
Onion (UNII: 492225Q21H)  
Cetearyl Glucoside (UNII: 09FUA47KNA)  
.Alpha.-Tocopherol Acetate (UNII: 9E8X80D2L0)  
Hyaluronate Sodium (UNII: YSE9PPT4TH)  
Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer (100000 Mpa.S At 1.5%) (UNII: 86FQE96TZ4)  
Hydroxyethyl Cellulose (2000 Mpa.S At 1%) (UNII: S38J6RZN16)  
Edetate Disodium Anhydrous (UNII: 8NLQ36F6MM)  
Bovine Type I Collagen (UNII: FHJ3ATL51C)  
Asiaticoside (UNII: PKO39VY215)  
Asiatic Acid (UNII: 9PA5A687X5)  
Madecassic Acid (UNII: M7O1N24J82)  
Polysorbate 60 (UNII: CAL22UVI4M)  
Sorbitan Isostearate (UNII: 01S2G2C1E4)  
Soy Protein (UNII: R44IWB3RN5)  
Sodium Hydroxide (UNII: 55X04QC32I)  
Tocopherol (UNII: R0ZB2556P8)  
Ferric Oxide Red (UNII: 1K09F3G675)  
Sodium Benzoate (UNII: OJ245FE5EU)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:73302-204-151 in 1 BOX10/01/2020
1150 g in 1 TUBE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC MONOGRAPH FINALpart34710/01/2020
Labeler - HRA Pharma America, Inc. (081160441)
Establishment
NameAddressID/FEIBusiness Operations
Merz Pharma GmbH & Co KGaA342543179manufacture(73302-204)

Revised: 3/2022
 
HRA Pharma America, Inc.